Pielago, Ivy .
HRN: 22-95-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/26/2023
04/29/2023
IV
500 Mg
Q8
G1P1 (1001) SP CSection
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes